FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1516044502> ?p ?o ?g. }

• W1516044502 endingPage "550" @default.
• W1516044502 startingPage "540" @default.
• W1516044502 abstract "Abstract Aim: The aim of this single‐blind, randomized, parallel‐designed clinical trial (RCT) was to evaluate the clinical and microbiological effects of three sustained‐release biodegradable polymers delivered into periodontal pockets following initial periodontal therapy. Methods: Forty‐seven patients (28 females and 19 males) with a mean age of 51 years (range 29–71) underwent a periodontal examination at baseline (i.e. Week 0) and after 18 weeks. This included the assessment of the Plaque Index (PlI), Bleeding on Probing (BOP), Pocket Probing Depths (PPD) and Probing Attachment Levels (PAL) at six sites per tooth. Two to 4 months prior to baseline, all subjects had received initial periodontal therapy including motivation, instruction in oral hygiene practices and full‐mouth scaling and root planing. At the treatment appointment (i.e. Week 2), the patients were randomly assigned to receive either Atridox™, Elyzol ® Dental Gel or PerioChip ® at all residual periodontal pockets with a probing depth ≥ 5 mm and concomitant BOP. In accordance with the manufacturer's recommendations, Elyzol ® Dental Gel was applied for a second time 7 days later. In addition to the clinical evaluation, subgingival microbiological samples were collected prior to treatment (i.e. Week 2) and at Weeks 4 and 18. Analysis of variance/covariance was used to evaluate changes from baseline to Week 18 for the clinical parameters. Results: Between the baseline and 18‐week examinations, subjects treated with Atridox showed a significantly greater gain in mean PAL of 0.33 mm ± 0.09 (SD) than subjects treated with Elyzol ® Dental Gel [0.03 mm ± 0.09 (SD)] (p = 0.03). However, the gain in PAL of 0.16 mm ± 0.10 (SD) found after PerioChip ® application did not differ significantly from that obtained following the application of Atridox TM (p = 0.27). Of the sites treated with Atridox TM , 42% gained ≥ 1 mm PAL and 9% ≥ 2 mm PAL as opposed to the sites treated with Elyzol ® Dental Gel, in which 34% gained ≥ 1 mm PAL and 8% gained ≥ 2 mm PAL. Of the sites treated with PerioChip ® , 36% gained ≥ 1 mm and 6% gained ≥ 2 mm PAL following a completed initial periodontal therapy. Conclusions: The application of the three biodegradable sustained release devices tested following initial periodontal therapy resulted in a statistically significant gain in mean PAL for Atridox TM and a significant reduction in PPD for all three devices during the study period. Furthermore, when sites treated with Atridox TM were compared with sites treated with Elyzol ® , a significant difference in mean PAL gain (0.3 mm) was observed." @default.
• W1516044502 created "2016-06-24" @default.
• W1516044502 creator A5016751033 @default.
• W1516044502 creator A5031631753 @default.
• W1516044502 creator A5032655443 @default.
• W1516044502 creator A5039131845 @default.
• W1516044502 creator A5055962179 @default.
• W1516044502 creator A5064144222 @default.
• W1516044502 creator A5073952077 @default.
• W1516044502 date "2002-06-01" @default.
• W1516044502 modified "2023-10-18" @default.
• W1516044502 title "Local antimicrobial therapy after initial periodontal treatment" @default.
• W1516044502 cites W1511929072 @default.
• W1516044502 cites W1862714762 @default.
• W1516044502 cites W1965450556 @default.
• W1516044502 cites W1966385208 @default.
• W1516044502 cites W1969628623 @default.
• W1516044502 cites W1976467741 @default.
• W1516044502 cites W1987373761 @default.
• W1516044502 cites W1992628620 @default.
• W1516044502 cites W2007433487 @default.
• W1516044502 cites W2007871979 @default.
• W1516044502 cites W2009206614 @default.
• W1516044502 cites W2015177492 @default.
• W1516044502 cites W2016513616 @default.
• W1516044502 cites W2017328348 @default.
• W1516044502 cites W2017582168 @default.
• W1516044502 cites W2036761085 @default.
• W1516044502 cites W2038963498 @default.
• W1516044502 cites W2049338184 @default.
• W1516044502 cites W2049557405 @default.
• W1516044502 cites W2052233772 @default.
• W1516044502 cites W2066815321 @default.
• W1516044502 cites W2072561299 @default.
• W1516044502 cites W2073227276 @default.
• W1516044502 cites W2073890620 @default.
• W1516044502 cites W2103872920 @default.
• W1516044502 cites W2107228383 @default.
• W1516044502 cites W2126544020 @default.
• W1516044502 cites W2141624962 @default.
• W1516044502 cites W2153036602 @default.
• W1516044502 cites W2153370336 @default.
• W1516044502 cites W2156236874 @default.
• W1516044502 cites W2160883018 @default.
• W1516044502 cites W2161897767 @default.
• W1516044502 cites W2161970303 @default.
• W1516044502 cites W2164002198 @default.
• W1516044502 cites W2175644368 @default.
• W1516044502 cites W2190152688 @default.
• W1516044502 doi "https://doi.org/10.1034/j.1600-051x.2002.290611.x" @default.
• W1516044502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12296782" @default.
• W1516044502 hasPublicationYear "2002" @default.
• W1516044502 type Work @default.
• W1516044502 sameAs 1516044502 @default.
• W1516044502 citedByCount "74" @default.
• W1516044502 countsByYear W15160445022012 @default.
• W1516044502 countsByYear W15160445022013 @default.
• W1516044502 countsByYear W15160445022014 @default.
• W1516044502 countsByYear W15160445022015 @default.
• W1516044502 countsByYear W15160445022016 @default.
• W1516044502 countsByYear W15160445022017 @default.
• W1516044502 countsByYear W15160445022018 @default.
• W1516044502 countsByYear W15160445022019 @default.
• W1516044502 countsByYear W15160445022020 @default.
• W1516044502 countsByYear W15160445022021 @default.
• W1516044502 countsByYear W15160445022022 @default.
• W1516044502 countsByYear W15160445022023 @default.
• W1516044502 crossrefType "journal-article" @default.
• W1516044502 hasAuthorship W1516044502A5016751033 @default.
• W1516044502 hasAuthorship W1516044502A5031631753 @default.
• W1516044502 hasAuthorship W1516044502A5032655443 @default.
• W1516044502 hasAuthorship W1516044502A5039131845 @default.
• W1516044502 hasAuthorship W1516044502A5055962179 @default.
• W1516044502 hasAuthorship W1516044502A5064144222 @default.
• W1516044502 hasAuthorship W1516044502A5073952077 @default.
• W1516044502 hasConcept C126322002 @default.
• W1516044502 hasConcept C168563851 @default.
• W1516044502 hasConcept C199343813 @default.
• W1516044502 hasConcept C2777968807 @default.
• W1516044502 hasConcept C2779337755 @default.
• W1516044502 hasConcept C2779416262 @default.
• W1516044502 hasConcept C2780385504 @default.
• W1516044502 hasConcept C515851188 @default.
• W1516044502 hasConcept C58747440 @default.
• W1516044502 hasConcept C71924100 @default.
• W1516044502 hasConceptScore W1516044502C126322002 @default.
• W1516044502 hasConceptScore W1516044502C168563851 @default.
• W1516044502 hasConceptScore W1516044502C199343813 @default.
• W1516044502 hasConceptScore W1516044502C2777968807 @default.
• W1516044502 hasConceptScore W1516044502C2779337755 @default.
• W1516044502 hasConceptScore W1516044502C2779416262 @default.
• W1516044502 hasConceptScore W1516044502C2780385504 @default.
• W1516044502 hasConceptScore W1516044502C515851188 @default.
• W1516044502 hasConceptScore W1516044502C58747440 @default.
• W1516044502 hasConceptScore W1516044502C71924100 @default.
• W1516044502 hasIssue "6" @default.
• W1516044502 hasLocation W15160445021 @default.
• W1516044502 hasLocation W15160445022 @default.

• next